← back to search

Beiping Miao

German Cancer Research Center · DE
Area of research
Molecular Biology · Pathology and Forensic Medicine
Research interest
Research interests include RNA modifications and cancer, Genetic factors in colorectal cancer, Advanced Nanomaterials in Catalysis, and Immunotherapy and Immune Responses.
h-index
18
citations
904
works
58
NIH funding
primary concept
Medicine
email

Recent publications

Prioritization of predisposition genes for familial non-medullary thyroid cancer by whole-genome sequencing
European Journal of Endocrinology 2025cited by 2position: middledoi
P2RY2 is a purinergic immune checkpoint linking extracellular ATP to immune evasion and adaptive resistance to immunotherapy
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 2position: middledoi
Dual Ribosome Profiling reveals metabolic limitations of cancer and stromal cells in the tumor microenvironment
Nature Communications 2025cited by 1position: middledoi
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
Cancer Cell 2024cited by 65position: middledoi
Deciphering the role of the MALT1–RC3H1 axis in regulating GPX4 protein stability
Proceedings of the National Academy of Sciences 2024cited by 12position: middledoi
Genome-Wide CRISPR Screen Identifies Genes Involved in Metastasis of Pancreatic Ductal Adenocarcinoma
Cancers 2024cited by 10position: middledoi
CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1
Cancer Cell 2023cited by 44position: firstdoi
Identification of a Novel Ferroptosis Inducer with Dual Modulatory Effects on GPX4 Activity and Stability
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 1position: middledoi
Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer
Cancers 2022cited by 25position: middledoi
Whole-Exome Sequencing Identifies a Novel Germline Variant in PTK7 Gene in Familial Colorectal Cancer
International Journal of Molecular Sciences 2022cited by 10position: firstdoi
Whole exome sequencing identifies novel germline variants of SLC15A4 gene as potentially cancer predisposing in familial colorectal cancer
Molecular Genetics and Genomics 2022cited by 4position: middledoi
Role of Chemokines in Colorectal Cancer
2022cited by 0position: middledoi
Whole Genome Sequencing Prioritizes CHEK2, EWSR1, and TIAM1 as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer
Frontiers in Endocrinology 2021cited by 18position: middledoi
Whole Exome Sequencing Identifies APCDD1 and HDAC5 Genes as Potentially Cancer Predisposing in Familial Colorectal Cancer
International Journal of Molecular Sciences 2021cited by 14position: middledoi
Promoter Hypermethylation Promotes the Binding of Transcription Factor NFATc1, Triggering Oncogenic Gene Activation in Pancreatic Cancer
Cancers 2021cited by 11position: middledoi
Transcription factor TFE3 enhances cell cycle and cancer progression by binding to the hTERT promoter
Cancer Communications 2021cited by 8position: firstdoi
Whole Exome Sequencing Identifies APCDD1 and HDAC5 Genes as Potentially Cancer Predisposing in Familial Colorectal Cancer
Preprints.org 2021cited by 2position: middledoi
Whole Exome Sequencing Identifies Novel Germline Variants of SLC15A4 Gene as Potentially Cancer Predisposing in Familial Colorectal Cancer
Preprints.org 2021cited by 2position: middledoi
A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal Cancer
Journal of Personalized Medicine 2021cited by 1position: middledoi
Role of DNA Mismatch Repair Genes in Colorectal Cancer
2021cited by 1position: middledoi
A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal Cancer
Preprints.org 2021cited by 1position: middledoi
Role of Epigenetics in Colorectal Cancer
2021cited by 0position: firstdoi
Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer
Preprints.org 2021cited by 0position: middledoi
A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer
Cancers 2020cited by 43position: middledoi
A novel germline mutation in the <i>POT1</i> gene predisposes to familial non-medullary thyroid cancer
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 8position: middledoi
The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation
International Journal of Cancer 2019cited by 22position: firstdoi
Exosome-like Nanozyme Vesicles for H<sub>2</sub>O<sub>2</sub>-Responsive Catalytic Photoacoustic Imaging of Xenograft Nasopharyngeal Carcinoma
Nano Letters 2018cited by 194position: middledoi
Immunoprofiling of Chlamydia trachomatis using whole-proteome microarrays generated by on-chip in situ expression
Scientific Reports 2018cited by 21position: middledoi
Expression and Regulation of Transcription Factor FoxA2 in Chronic Rhinosinusitis With and Without Nasal Polyps
Allergy Asthma and Immunology Research 2015cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Obul Reddy Bandapalli · German Cancer Research Center17 papers (2020–2025)Asta Försti · German Cancer Research Center13 papers (2020–2025)Nagarajan Paramasivam · National Center for Tumor Diseases13 papers (2020–2025)Kari Hemminki · Lund University13 papers (2020–2025)Abhishek Kumar · Manipal Academy of Higher Education12 papers (2020–2025)Diamanto Skopelitou · German Cancer Research Center11 papers (2020–2025)Aayushi Srivastava · German Cancer Research Center11 papers (2020–2025)Jan Lubiński · Radboud University Medical Center9 papers (2021–2022) · 9 papers (2021–2022)Matthias Schlesner · University of Augsburg9 papers (2021–2022) · 7 papers (2021–2022)Jörg D. Hoheisel · German Cancer Research Center5 papers (2018–2024)Chong Sun · German Cancer Research Center4 papers (2023–2025)Andrea S. Bauer · Boston Children's Hospital4 papers (2018–2024)Sonal Gupta · Fortis Healthcare3 papers (2021–2022) · 3 papers (2021–2022)Prashanth Suravajhala · Mississippi State University3 papers (2021–2022) · 3 papers (2020–2021)Katrin Hufnagel · Epigenomics (Germany)3 papers (2018–2021)Lizhen Zhu · Tsinghua University2 papers (2021–2022)